Anatomical Therapeutic Chemical • L01XM04 • vorasidenib

L Antineoplastic and immunomodulating agents

L01 Antineoplastic agents

L01A Alkylating agents

L01B Antimetabolites

L01C Plant alkaloids and other natural products

L01D Cytotoxic antibiotics and related substances

L01E Protein kinase inhibitors

L01F Monoclonal antibodies and antibody drug conjugates

L01X Other antineoplastic agents

L01XA Platinum compounds

L01XB Methylhydrazines

L01XC Monoclonal antibodies

L01XD Sensitizers used in photodynamic/radiation therapy

L01XF Retinoids for cancer treatment

L01XG Proteasome inhibitors

L01XH Histone deacetylase (HDAC) inhibitors

L01XJ Hedgehog pathway inhibitors

L01XK Poly (ADP-ribose) polymerase (PARP) inhibitors

L01XL Antineoplastic cell and gene therapy

L01XM Isocitrate dehydrogenase (IDH) inhibitors

L01XM02 ivosidenib Indicated for: hematologic malignancies

L01XM04 vorasidenib Indicated for: cancer

L01XU Other antineoplastic agents (cont.)

L01XX Other antineoplastic agents

L01XY Combinations of antineoplastic agents

L02 Endocrine therapy

L03 Immunostimulants

L04 Immunosuppressants